Panacea Biotec Limited has informed the Exchange regarding Appointment of Mr. Vinod Goel as Chief Financial Officer of the company w.e.f. December 16, 2025.
PANACEABIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Panacea Biotec Limited has announced the appointment of Mr. Vinod Goel as the new Chief Financial Officer (CFO) of the company, effective December 16, 2025. This is a key managerial personnel (KMP) change at the financial leadership level. The announcement does not provide further details on whether this is an internal promotion or an external hire, nor does it mention the previous CFO's departure. Investors may want to monitor the company's next filings for more context on this transition.
This appointment brings a new CFO at a critical financial leadership position; investors should watch for clarity on the prior CFO's status and assess Mr. Goel's track record, though the announcement itself is largely procedural.